Cefaloglycin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
'''Cefaloglycin''' is a | '''Cefaloglycin''' is a [[cephalosporin]] [[antibiotic]] used in the treatment of various bacterial infections. It belongs to the first generation of cephalosporins and is known for its effectiveness against [[Gram-positive bacteria]]. | ||
== | ==Chemical structure== | ||
Cefaloglycin is characterized by its beta-lactam ring, which is crucial for its antibacterial activity. The presence of the beta-lactam ring allows cefaloglycin to inhibit bacterial cell wall synthesis, leading to cell lysis and death. | |||
== | ==Mechanism of action== | ||
Cefaloglycin works by | Cefaloglycin works by binding to [[penicillin-binding proteins]] (PBPs) located inside the bacterial cell wall. This binding inhibits the final transpeptidation step of [[peptidoglycan]] synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. The inhibition of cell wall synthesis ultimately leads to bacterial cell death. | ||
== | ==Pharmacokinetics== | ||
Cefaloglycin is | Cefaloglycin is administered orally and is absorbed from the gastrointestinal tract. It is distributed widely in body tissues and fluids. The drug is primarily excreted unchanged in the urine, making it effective for treating urinary tract infections. | ||
== | ==Clinical uses== | ||
Cefaloglycin is used to treat a variety of infections caused by susceptible strains of bacteria. These include: | |||
* [[Urinary tract infections]] | |||
* [[Respiratory tract infections]] | |||
* [[Skin and soft tissue infections]] | |||
==Related | ==Side effects== | ||
Common side effects of cefaloglycin include gastrointestinal disturbances such as [[nausea]], [[vomiting]], and [[diarrhea]]. Allergic reactions, though rare, can occur and may manifest as [[rash]], [[pruritus]], or more severe reactions such as [[anaphylaxis]]. | |||
==Related pages== | |||
* [[Cephalosporin]] | * [[Cephalosporin]] | ||
* [[Antibiotic | * [[Antibiotic]] | ||
* [[ | * [[Beta-lactam antibiotic]] | ||
[[Category:Cephalosporin antibiotics]] | |||
[[Category:Beta-lactam antibiotics]] | |||
Latest revision as of 03:08, 25 February 2026
Cefaloglycin is a cephalosporin antibiotic used in the treatment of various bacterial infections. It belongs to the first generation of cephalosporins and is known for its effectiveness against Gram-positive bacteria.
Chemical structure[edit]
Cefaloglycin is characterized by its beta-lactam ring, which is crucial for its antibacterial activity. The presence of the beta-lactam ring allows cefaloglycin to inhibit bacterial cell wall synthesis, leading to cell lysis and death.
Mechanism of action[edit]
Cefaloglycin works by binding to penicillin-binding proteins (PBPs) located inside the bacterial cell wall. This binding inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. The inhibition of cell wall synthesis ultimately leads to bacterial cell death.
Pharmacokinetics[edit]
Cefaloglycin is administered orally and is absorbed from the gastrointestinal tract. It is distributed widely in body tissues and fluids. The drug is primarily excreted unchanged in the urine, making it effective for treating urinary tract infections.
Clinical uses[edit]
Cefaloglycin is used to treat a variety of infections caused by susceptible strains of bacteria. These include:
Side effects[edit]
Common side effects of cefaloglycin include gastrointestinal disturbances such as nausea, vomiting, and diarrhea. Allergic reactions, though rare, can occur and may manifest as rash, pruritus, or more severe reactions such as anaphylaxis.
